Picture of China NT Pharma Co logo

1011 China NT Pharma Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for China NT Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-149-54.3-33.4-53.5-26.3
Depreciation
Amortisation
Non-Cash Items64.782.7-2.740.613.9
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-93-13.280.73.156.33
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-13536.250.5-9.07-5.39
Capital Expenditures-0.646-4.49-10.7-0.178-0.159
Purchase of Fixed Assets
Other Investing Cash Flow Items2589.02-11.4-0.0110.007
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2584.53-22.1-0.189-0.152
Financing Cash Flow Items-43.3-19.7-19.2-9.98-19.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-125-46.7-2912.74.87
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.61-2.45-0.3968.1-2.4